Portola Pharmaceuticals' IPO

Portola Pharmaceuticals raised a round of funding on May 22, 2013. Investors include Public.

Portola is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who curren…

Articles about Portola Pharmaceuticals' IPO: